T. Rowe Price Associates
HNGE

T. Rowe Price Associates’s Hinge Health HNGE Stock Holding History

T. Rowe Price Associates’s Portfolio HNGE Stock Details HNGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.85M Buy
+34,323
New +$1.86M ﹤0.01% 1835

Other funds holding HNGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
12CM
11.2 Capital Management Las Vegas, Nevada $205M AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

T. Rowe Price Associates's HNGE Position: Q2 2026 in Review

T. Rowe Price Associates opened a new position in Hinge Health (HNGE) in Q2 2026: 34,323 shares worth $2.85M. The stake represents ﹤0.01% of the portfolio and ranks #1835 among its holdings.

277 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

  • T. Rowe Price Associates held 34,323 shares of Hinge Health worth $2.85M as of Q2 2026.
  • Hinge Health was a new T. Rowe Price Associates position in Q2 2026.
  • Hinge Health made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #1835 holding.
  • 277 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.